General MedicationsTOPICALStandard
SYNALAR
FLUOCINOLONE ACETONIDE
Standard Dose
0.01%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SYNALAR is listed in Drugs@FDA under application 015296 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINOLONE ACETONIDE Form and strength SOLUTION;TOPICAL - 0.01% Sponsor EUROFARMA Submission history Latest submission status date: 2012-11-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview SYNALAR is listed in Drugs@FDA under application 015296 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINOLONE ACETONIDE Form and strength SOLUTION;TOPICAL - 0.01% Sponsor EUROFARMA Submission history Latest submission status date: 2012-11-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.